Stockreport

Lineage Cell Therapeutics: Not Yet Attractive Stem Cell Company [Seeking Alpha]

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF The company has treated over 50 patients with no rejections and has seen 5 cases of retinal regeneration on a single administration per patient. Lead asset OpRegen is [Read more]